Aprepitant for erlotinib-induced pruritus

N Engl J Med. 2010 Oct 21;363(17):1680-1; author reply 1681. doi: 10.1056/NEJMc1009698.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antineoplastic Agents / adverse effects
  • Aprepitant
  • Area Under Curve
  • Cytochrome P-450 CYP3A
  • Cytochrome P-450 CYP3A Inhibitors*
  • Drug Administration Schedule
  • Drug Interactions
  • Erlotinib Hydrochloride
  • Humans
  • Morpholines / administration & dosage*
  • Neurokinin-1 Receptor Antagonists*
  • Off-Label Use
  • Protein Kinase Inhibitors / adverse effects
  • Pruritus / chemically induced
  • Pruritus / drug therapy*
  • Quinazolines / adverse effects
  • Quinazolines / pharmacokinetics*

Substances

  • Antineoplastic Agents
  • Cytochrome P-450 CYP3A Inhibitors
  • Morpholines
  • Neurokinin-1 Receptor Antagonists
  • Protein Kinase Inhibitors
  • Quinazolines
  • Aprepitant
  • Erlotinib Hydrochloride
  • Cytochrome P-450 CYP3A
  • CYP3A4 protein, human